Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Older than 18 years~* Prior diagnosis of Crohn's disease~* patients who have Crohn's fistula~* negative for serum beta-HCG for woman of childbearing age~* agreement to participate, with signed informed-consent~Exclusion Criteria:~* patients who have allergy to bovine-derived materials or an anesthetic~* patients with a diagnosis of auto immune disease except for Crohn's disease~* Diagnosis of HBV, HCV, HIV and other infectious disease~* Patients who have a symptom of septicemia~* Patients with a diagnosis of active Tuberculosis~* Patient who are pregnant or breast-feeding~* Patients who are unwilling to use an effective method of contraception during the study~* Patients with a diagnosis of Inflammatory Bowel Disease except for Crohn's disease~* Patients who are sensitive to Fibrin glue~* Patients who have a clinically relevant history of abuse of alcohol or drugs, habitual smoker~* Insufficient adipose tissue for manufacturing of ADIPOPLUS~* Patients who are considered not suitable for the study by investigator~* Patients with a diagnosis of active refractory Crohn's disease~* Patients who have history of surgery for malignant cancer in the past 5 years~* Patients who have \> 2 cm diameter of fistula

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ADIPOPLUS (Type: EXPERIMENTAL): patients with a fistula in Crohn's disease

Based on this trial design, predict the completion outcome and termination type (if applicable).